Palbociclib Appears to Prolong Progression Free Survival in Women with Metastatic Breast Cancer

As for 10 months of PFS, that’s valuable. Imagine that you’re 55 years old and living with metastatic breast cancer. A drug that is likely to delay, by most of 2 years, your tumor’s expansion into the lungs …A concern I have is that this study wasn’t blinded,

Posted in Breast Cancer, cancer survival, cancer treatment, Medical News, Oncology (cancer), PharmacologyTagged , , , , , , , , , 2 Comments on Palbociclib Appears to Prolong Progression Free Survival in Women with Metastatic Breast Cancer

Considering Aromasin for Healthy Women, and the New Breast Cancer Prevention Study

I’m minding the annual meeting of the American Society of Clinical Oncology from a distance this year. So far, the big breast cancer story syncs with a NEJM paper published yesterday on-line, on the use of exemestane (brand name: Aromasin, manufactured by Pfizer) to prevent invasive breast cancer. These patent-protected pills block the body’s normal […]

Posted in Breast Cancer, clinical trials, Medical News, Oncology (cancer), Women's HealthTagged , , , , , , , Leave a Comment on Considering Aromasin for Healthy Women, and the New Breast Cancer Prevention Study
newsletter software